Cargando…

Insulin-Like Growth Factors and Their Binding Proteins in Tumors and Ascites of Ovarian Cancer Patients: Association With Response To Neoadjuvant Chemotherapy

PURPOSE: Tumor cell growth and sensitivity to chemotherapy depend on many factors, among which insulin-like growth factors (IGFs) may play important roles. The aim of the present study was to evaluate the levels of insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) in primary tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yunusova, Natalia V, Villert, Alisa B, Spirina, Liudmila V, Frolova, Alena E, Kolomiets, Larisa A, Kondakova, Irina V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454676/ https://www.ncbi.nlm.nih.gov/pubmed/28125879 http://dx.doi.org/10.22034/APJCP.2016.17.12.5315

Ejemplares similares

Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome
por: Yunusova, Natalia, et al.
Publicado: (2021)

Comparative Analysis of Tumor-Associated microRNAs and Tetraspanines from Exosomes of Plasma and Ascitic Fluids of Ovarian Cancer Patients
por: Yunusova, Natalia, et al.
Publicado: (2022)

Transcription factors Brn-3α and TRIM16 in cancers, association with hormone reception
por: Spirina, Liudmila V., et al.
Publicado: (2019)

Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components
por: Rakina, Militsa, et al.
Publicado: (2022)

Protease Cargo in Circulating Exosomes of Breast Cancer and Ovarian Cancer Patients
por: Tamkovich, Svetlana N, et al.
Publicado: (2019)

The Association of the BRAF-V600E Mutation with the Expression of the Molecular Markers in the Primary Tumor and Metastatic Tissue in Papillary Thyroid Cancer
por: Spirina, Liudmila V., et al.
Publicado: (2021)

Extraskeletal myxoid chondrosarcoma of the vulva: A case report
por: VILLERT, ALISA, et al.
Publicado: (2015)

Progesterone Receptor Expression in the Benign Prostatic Hyperplasia and Prostate Cancer Tissues, Relation with Transcription, Growth Factors, Hormone Reception and Components of the AKT/mTOR Signaling Pathway
por: Spirina, Liudmila V, et al.
Publicado: (2020)

Effect of Targeted Therapy With Pazopanib on Expression Levels of Transcription, Growth Factors and Components of AKT/m-TOR Signaling Pathway in Patients with Renal Cell Carcinoma
por: Spirina, Liudmila V, et al.
Publicado: (2017)

LC3B, mTOR, AMPK Are Molecular Targets for Neoadjuvant Chemotherapy in Gastric Cancers
por: Spirina, Liudmila V., et al.
Publicado: (2022)

Functional activity of natural killer cells in biological fluids in patients with colorectal and ovarian cancers
por: Yunusova, Natalia V, et al.
Publicado: (2018)

Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2
por: Spirina, Liudmila, et al.
Publicado: (2021)

Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy——AKT/m-TOR Pathway and Resistance to Cancer Therapy
por: SPIRINA, Liudmila V, et al.
Publicado: (2018)

Safety and Efficacy of Neoadjuvant Chemoimmunotherapy in Gastric Cancer Patients with a PD-L1 Positive Status: A Case Report
por: Avgustinovich, Alexandra V., et al.
Publicado: (2023)

Draft Genome Sequence of Microbacterium sp. Gd 4-13, Isolated from Gydanskiy Peninsula Permafrost Sediments of Marine Origin
por: Spirina, Elena V., et al.
Publicado: (2019)

Amplifications of Stemness Gene Loci—New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective Study
por: Litviakov, Nikolai V., et al.
Publicado: (2021)

Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2016)

Autophagy-Related MicroRNA: Tumor miR-125b and Thyroid Cancers
por: Spirina, Liudmila V., et al.
Publicado: (2023)

The Role of Intravesicular Proteins and the Protein Corona of Extracellular Vesicles in the Development of Drug-Induced Polyneuropathy
por: Yunusova, Natalia V., et al.
Publicado: (2023)

SARS-CoV2 Infection and Comorbidities, Role in Oncogenesis
por: Spirina, Liudmila V, et al.
Publicado: (2022)

Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
por: Patel, Ami, et al.
Publicado: (2021)

Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites
por: den Ouden, Judith E., et al.
Publicado: (2020)

DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease
por: Tsyganov, Matvey M., et al.
Publicado: (2022)

Exosomal Protease Cargo as Prognostic Biomarker in Colorectal Cancer
por: Yunusova, Natalia V., et al.
Publicado: (2021)

Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
por: Ahmed, Nuzhat, et al.
Publicado: (2016)

Molecular Protein and Expression Profile in the Primary Tumors of Clear Cell Renal Carcinoma and Metastases
por: Spirina, Liudmila V., et al.
Publicado: (2020)

Relation between Tetraspanin- Associated and Tetraspanin-Non- Associated Exosomal Proteases and Metabolic Syndrome in Colorectal Cancer Patients
por: Tugutova, Elena A, et al.
Publicado: (2019)

Estrogen Receptors and Ubiquitin Proteasome System: Mutual Regulation
por: Kondakova, Irina V., et al.
Publicado: (2020)

Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma
por: Hegazy, Mohamed AF, et al.
Publicado: (2005)

Role of Neoadjuvant Chemotherapy in Ovarian Serous Cancer Followed by Debulking
por: Chauhan, Sonali, et al.
Publicado: (2022)

Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer
por: Liu, Min, et al.
Publicado: (2022)

Neoadjuvant chemotherapy in advanced-stage ovarian cancer – state of the art
por: Margioula-Siarkou, Chrysoula, et al.
Publicado: (2022)

Conversion therapy of gastric cancer with massive malignant ascites and ovarian metastases by systemic and intraperitoneal chemotherapy
por: Kondo, Tomohiro, et al.
Publicado: (2016)

Ascitic complement system in ovarian cancer
por: Bjørge, L, et al.
Publicado: (2005)

The bright side of ascites in ovarian cancer
por: Cohen, Marie, et al.
Publicado: (2014)

Ascites Volumes and the Ovarian Cancer Microenvironment
por: Penet, Marie-France, et al.
Publicado: (2018)

Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment
por: Escalona, Ruth M., et al.
Publicado: (2022)

Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer
por: Reijonen, Milja, et al.
Publicado: (2023)

Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer
por: Kaigorodova, Evgeniya V., et al.
Publicado: (2018)

A Criterion of Colorectal Cancer Diagnosis Using Exosome Fluorescence-Lifetime Imaging
por: Borisov, Alexey V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e9e9ng6ecgcjqk8mm9g1a953o4